Schizophrenia Clinical Trial
Official title:
Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia
Cognitive dysfunction is a major contributor to the poor community outcome of individuals with schizophrenia. Developing more effective cognitive remediation interventions is imperative to improve the daily lives of affected subjects and reduce the disability of this illness. The goal of this clinical trial is to evaluate two types of cognitive training approaches to determine which one is more beneficial for individuals with schizophrenia. This study also uses electrophysiological techniques to gain a better understanding of the mechanisms involved in cognitive remediation. Findings from this study will provide information about how to design the most optimally efficient cognitive training intervention to improve the cognitive and social functioning of patients with severe mental illness.
Schizophrenia is a disorder that affects both higher-level neurocognitive operations (e.g.,
verbal memory, executive functioning) and lower-level perceptual processes (e.g., auditory
processing). These deficits contribute to the poor community outcome and severe functional
disability seen in patients. Effectively treating the cognitive dysfunction associated with
this illness is important to achieve improvements in daily functioning. Recent meta-analytic
studies report that cognitive training in schizophrenia has a moderate effect-size impact on
cognitive functioning and a lower impact on daily functioning. However, most training
interventions for schizophrenia have only targeted higher-order cognitive processes. A few
recent interventions have targeted basic perceptual processing and shown that auditory and
visual perceptual abilities can be trained and improved in patients with schizophrenia. These
findings suggest that basic perceptual processing may be an ideal target for intervention. At
this point, it is still unclear whether a neuroplasticity-based, bottom-up intervention is
more effective than an intervention that targets top-down functions like attention, working
memory, and executive functioning.
This clinical trial will contrast a bottom-up intervention targeting basic auditory processes
and a top-down intervention targeting higher-order cognitive functions, compared with a
control condition, in Veterans with schizophrenia. These interventions will be assessed by
their effects on representative measures from three outcome domains: 1) neurocognition, 2)
electroencephalography (EEG), and 3) functional capacity. Participants will be randomly
assigned to the bottom-up auditory training, top-down cognitive training, or control
treatment (commercial computer games). All treatments will be administered three times a week
(1 hour each) for 12 weeks. A comprehensive battery of cognitive, electrophysiological, and
functional measures will be administered at baseline, 6 weeks, and at completion of
treatment. The investigators will enroll 120 Veterans with schizophrenia or schizoaffective
disorder across the 5 years of the study.
This study will determine which training approach leads to the largest magnitude of
improvement in neurocognition, functional capacity, and neural functioning measured with EEG.
Moreover, it will shed light on the neural mechanisms underlying the response to training. By
determining whether it is more beneficial to treat lower-level perceptual processes or
higher-level cognitive functions, the results of this project will inform future
recovery-based cognitive remediation interventions for Veterans with schizophrenia.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |